| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Analysts' ratings for Allstate (NYSE:ALL) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 6 | 1 | 1 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 2 | 0 | 0 | 0 |
| 3M Ago | 1 | 2 | 1 | 1 | 0 |
Analysts have recently evaluated Allstate and provided 12-month price targets. The average target is $218.36, accompanied by a high estimate of $260.00 and a low estimate of $22.00. Witnessing a positive shift, the current average has risen by 4.93% from the previous average price target of $208.10.
The perception of Allstate by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jimmy Bhullar | JP Morgan | Raises | Overweight | $254.00 | $235.00 |
| Brian Meredith | UBS | Raises | Buy | $250.00 | $235.00 |
| Tracy Benguigui | Wolfe Research | Announces | Outperform | $235.00 | - |
| Michael Zaremski | BMO Capital | Raises | Outperform | $235.00 | $230.00 |
| Paul Newsome | Piper Sandler | Raises | Overweight | $22.00 | $20.00 |
| Andrew Andersen | Jefferies | Raises | Buy | $255.00 | $254.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $246.00 | $237.00 |
| Elyse Greenspan | Wells Fargo | Raises | Equal-Weight | $202.00 | $197.00 |
| C. Gregory Peters | Raymond James | Raises | Strong Buy | $260.00 | $250.00 |
| Bob Huang | Morgan Stanley | Raises | Overweight | $245.00 | $235.00 |
| Alex Scott | Barclays | Raises | Underweight | $198.00 | $188.00 |
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Allstate's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Allstate analyst ratings.
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining Allstate's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.9% as of 30 June, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Allstate's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 12.57%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Allstate's ROE stands out, surpassing industry averages. With an impressive ROE of 9.88%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.8%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.37, caution is advised due to increased financial risk.
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ALL
